Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
1 Year
N/A
Both
Basal Cell Carcinoma
Trial Information
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
Perturbations in the expression profiles of microRNAs (miRNAs) have been reported for a
variety of different cancers. Basal cell carcinoma (BCC) of the skin has not been
systematically evaluated regarding differentially expressed miRNAs. Patients with BCC are
included in the study to perform an exploratory analysis by miRNA expression profiling using
microarrays. Expression levels of miRNA candidates will be validated by TaqMan real-time
quantitative polymerase chain reaction (RT-PCR).
Inclusion Criteria:
- Basal Cell Carcinoma
Exclusion Criteria:
- Other Skin Cancer than Basal Cell Carcinoma
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Principal Investigator
Falk G Bechara, PD Dr.
Investigator Role:
Study Director
Investigator Affiliation:
Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum
Authority:
Germany: Ethics Commission
Study ID:
microRNA6
NCT ID:
NCT01498250
Start Date:
November 2011
Completion Date:
December 2011
Related Keywords:
- Basal Cell Carcinoma
- Carcinoma
- Carcinoma, Basal Cell
Name | Location |
|---|
